RUNX3 and cancer: In conclusion, in HCT116 and HT29 cell strains, knocking out EZH2 may promote expressions of proteins related to the Wnt/β-catenin signaling pathway through inhibiting RUNX3, which in turn suppresses the cancer cellular proliferation, invasion and migration while promoting apoptosis.